Skip to main content
. 2025 May 30;25:967. doi: 10.1186/s12885-025-14370-y

Table 2.

TEAE(≥ 20%) in the SS

TEAEs, n (%) 40 mg BID (n = 4) 60 mg BID (n = 3) 80 mg BID (n = 4) Total (n = 11)
Any grade  ≥ Grade 3 Any grade  ≥ Grade 3 Any grade  ≥ Grade 3 Any grade  ≥ Grade 3
Any TEAEs 4 (100) 1 (25.0) 3 (100) 2 (66.7) 4 (100) 2 (50.0) 11 (100) 5 (45.5)
Hypertriglyceridemia 1 (25.0) 2 (66.7) 1 (33.3) 3 (75.0) 2 (50.0) 6 (54.5) 3 (27.3)
Neutropenia 1 (25.0) 1 (33.3) 3 (75.0) 5 (45.5)
Hypoalbuminemia 2 (50.0) 2 (66.7) 1 (25.0) 5 (45.5)
Hypoproteinemia 1 (25.0) 2 (66.7) 2 (50.0) 5 (45.5)
Thrombocytopenia 2 (50.0) 1 (25.0) 2 (66.7) 1 (33.3) 1 (25.0) 5 (45.5) 2 (18.2)
Abnormal T-wave on electrocardiogram 0 1 (33.3) 3 (75.0) 4 (36.4)
Leukopenia 0 1 (33.3) 3 (75.0) 4 (36.4)
Diarrhea 0 1 (33.3) 3 (75.0) 4 (36.4)
Fatigue 1 (25.0) 1 (33.3) 2 (50.0) 4 (36.4)
Anemia 1 (25.0) 1 (33.3) 2 (50.0) 4 (36.4)
Elevated α-hydroxybutyrate dehydrogenase 1 (25.0) 1 (33.3) 1 (25.0) 3 (27.3)
Elevated low-density lipoprotein 1 (25.0) 2 (66.7) 0 3 (27.3)
Urinary white blood cell positivity 1 (25.0) 1 (33.3) 1 (25.0) 3 (27.3)
Abnormal ST segment on electrocardiogram 0 1 (33.3) 2 (50.0) 3 (27.3)
Nausea 0 1 (33.3) 2 (50.0) 3 (27.3)
Lymphopenia 0 1 (33.3) 2 (50.0) 3 (27.3)
Hyperuricemia 1 (25.0) 1 (33.3) 1 (25.0) 3 (27.3)
Hypercholesterolemia 1 (25.0) 1 (33.3) 1 (25.0) 3 (27.3)
Hyperglycemia 1 (25.0) 0 2 (50.0) 1 (25.0) 3 (27.3) 1 (9.1)